Selected research
Industry Research
Plasma Fractionation Technology Industry Research Report 2026
Market perspective
The global Plasma Fractionation Technology market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Plasma Fractionation Technology market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Plasma Fractionation Technology market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Plasma Fractionation Technology market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Plasma Fractionation Technology include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and RAAS, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Plasma Fractionation Technology market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Plasma Fractionation Technology.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Plasma Fractionation Technology Market by Company
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Nanyue Bio
KM Biologics
Plasma Fractionation Technology Segment by Type
Immune Globulin
Coagulation Factor
Albumin
Other
Plasma Fractionation Technology Segment by Application
Hospital
Retail Pharmacy
Other
Plasma Fractionation Technology Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Fractionation Technology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plasma Fractionation Technology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Fractionation Technology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Plasma Fractionation Technology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Immune Globulin
- Coagulation Factor
- Albumin
- Other
Applications
- Hospital
- Retail Pharmacy
- Other
Companies covered
- Takeda
- CSL
- Grifols
- Octapharma
- Kedrion
- LFB Group
- Biotest
- BPL
- RAAS
- CBPO
- Hualan Bio
- Tiantan Bio
- Shuanglin Bio
- Boya Bio
- Yuanda Shuyang
- Weiguang Bio
- Nanyue Bio
- KM Biologics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Plasma Fractionation Technology by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Immune Globulin
- 2.2.3 Coagulation Factor
- 2.2.4 Albumin
- 2.2.5 Other
- 2.3 Plasma Fractionation Technology by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Retail Pharmacy
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 Plasma Fractionation Technology Breakdown Data by Type
- 3.1 Global Plasma Fractionation Technology Historic Market Size by Type (2021-2026)
- 3.2 Global Plasma Fractionation Technology Forecasted Market Size by Type (2027-2032)
4 Plasma Fractionation Technology Breakdown Data by Application
- 4.1 Global Plasma Fractionation Technology Historic Market Size by Application (2021-2026)
- 4.2 Global Plasma Fractionation Technology Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Plasma Fractionation Technology Market Perspective (2021-2032)
- 5.2 Global Plasma Fractionation Technology Growth Trends by Region
- 5.2.1 Global Plasma Fractionation Technology Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Plasma Fractionation Technology Historic Market Size by Region (2021-2026)
- 5.2.3 Plasma Fractionation Technology Forecasted Market Size by Region (2027-2032)
- 5.3 Plasma Fractionation Technology Market Dynamics
- 5.3.1 Plasma Fractionation Technology Industry Trends
- 5.3.2 Plasma Fractionation Technology Market Drivers
- 5.3.3 Plasma Fractionation Technology Market Challenges
- 5.3.4 Plasma Fractionation Technology Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Plasma Fractionation Technology Players by Revenue
- 6.1.1 Global Top Plasma Fractionation Technology Players by Revenue (2021-2026)
- 6.1.2 Global Plasma Fractionation Technology Revenue Market Share by Players (2021-2026)
- 6.2 Global Plasma Fractionation Technology Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Plasma Fractionation Technology Head Office and Area Served
- 6.4 Global Plasma Fractionation Technology Players, Product Type & Application
- 6.5 Global Plasma Fractionation Technology Manufacturers Established Date
- 6.6 Global Plasma Fractionation Technology Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Plasma Fractionation Technology Market Size (2021-2032)
- 7.2 North America Plasma Fractionation Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Plasma Fractionation Technology Market Size by Country (2021-2026)
- 7.4 North America Plasma Fractionation Technology Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Plasma Fractionation Technology Market Size (2021-2032)
- 8.2 Europe Plasma Fractionation Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Plasma Fractionation Technology Market Size by Country (2021-2026)
- 8.4 Europe Plasma Fractionation Technology Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Plasma Fractionation Technology Market Size (2021-2032)
- 9.2 Asia-Pacific Plasma Fractionation Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Plasma Fractionation Technology Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Plasma Fractionation Technology Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Plasma Fractionation Technology Market Size (2021-2032)
- 10.2 South America Plasma Fractionation Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Plasma Fractionation Technology Market Size by Country (2021-2026)
- 10.4 South America Plasma Fractionation Technology Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Plasma Fractionation Technology Market Size (2021-2032)
- 11.2 Middle East & Africa Plasma Fractionation Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Plasma Fractionation Technology Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Plasma Fractionation Technology Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Takeda
- 12.1.1 Takeda Company Information
- 12.1.2 Takeda Business Overview
- 12.1.3 Takeda Revenue in Plasma Fractionation Technology Business (2021-2026)
- 12.1.4 Takeda Plasma Fractionation Technology Product Portfolio
- 12.1.5 Takeda Recent Developments
- 12.2 CSL
- 12.2.1 CSL Company Information
- 12.2.2 CSL Business Overview
- 12.2.3 CSL Revenue in Plasma Fractionation Technology Business (2021-2026)
- 12.2.4 CSL Plasma Fractionation Technology Product Portfolio
- 12.2.5 CSL Recent Developments
- 12.3 Grifols
- 12.3.1 Grifols Company Information
- 12.3.2 Grifols Business Overview
- 12.3.3 Grifols Revenue in Plasma Fractionation Technology Business (2021-2026)
- 12.3.4 Grifols Plasma Fractionation Technology Product Portfolio
- 12.3.5 Grifols Recent Developments
- 12.4 Octapharma
- 12.4.1 Octapharma Company Information
- 12.4.2 Octapharma Business Overview
- 12.4.3 Octapharma Revenue in Plasma Fractionation Technology Business (2021-2026)
- 12.4.4 Octapharma Plasma Fractionation Technology Product Portfolio
- 12.4.5 Octapharma Recent Developments
- 12.5 Kedrion
- 12.5.1 Kedrion Company Information
- 12.5.2 Kedrion Business Overview
- 12.5.3 Kedrion Revenue in Plasma Fractionation Technology Business (2021-2026)
- 12.5.4 Kedrion Plasma Fractionation Technology Product Portfolio
- 12.5.5 Kedrion Recent Developments
- 12.6 LFB Group
- 12.6.1 LFB Group Company Information
- 12.6.2 LFB Group Business Overview
- 12.6.3 LFB Group Revenue in Plasma Fractionation Technology Business (2021-2026)
- 12.6.4 LFB Group Plasma Fractionation Technology Product Portfolio
- 12.6.5 LFB Group Recent Developments
- 12.7 Biotest
- 12.7.1 Biotest Company Information
- 12.7.2 Biotest Business Overview
- 12.7.3 Biotest Revenue in Plasma Fractionation Technology Business (2021-2026)
- 12.7.4 Biotest Plasma Fractionation Technology Product Portfolio
- 12.7.5 Biotest Recent Developments
- 12.8 BPL
- 12.8.1 BPL Company Information
- 12.8.2 BPL Business Overview
- 12.8.3 BPL Revenue in Plasma Fractionation Technology Business (2021-2026)
- 12.8.4 BPL Plasma Fractionation Technology Product Portfolio
- 12.8.5 BPL Recent Developments
- 12.9 RAAS
- 12.9.1 RAAS Company Information
- 12.9.2 RAAS Business Overview
- 12.9.3 RAAS Revenue in Plasma Fractionation Technology Business (2021-2026)
- 12.9.4 RAAS Plasma Fractionation Technology Product Portfolio
- 12.9.5 RAAS Recent Developments
- 12.10 CBPO
- 12.10.1 CBPO Company Information
- 12.10.2 CBPO Business Overview
- 12.10.3 CBPO Revenue in Plasma Fractionation Technology Business (2021-2026)
- 12.10.4 CBPO Plasma Fractionation Technology Product Portfolio
- 12.10.5 CBPO Recent Developments
- 12.11 Hualan Bio
- 12.11.1 Hualan Bio Company Information
- 12.11.2 Hualan Bio Business Overview
- 12.11.3 Hualan Bio Revenue in Plasma Fractionation Technology Business (2021-2026)
- 12.11.4 Hualan Bio Plasma Fractionation Technology Product Portfolio
- 12.11.5 Hualan Bio Recent Developments
- 12.12 Tiantan Bio
- 12.12.1 Tiantan Bio Company Information
- 12.12.2 Tiantan Bio Business Overview
- 12.12.3 Tiantan Bio Revenue in Plasma Fractionation Technology Business (2021-2026)
- 12.12.4 Tiantan Bio Plasma Fractionation Technology Product Portfolio
- 12.12.5 Tiantan Bio Recent Developments
- 12.13 Shuanglin Bio
- 12.13.1 Shuanglin Bio Company Information
- 12.13.2 Shuanglin Bio Business Overview
- 12.13.3 Shuanglin Bio Revenue in Plasma Fractionation Technology Business (2021-2026)
- 12.13.4 Shuanglin Bio Plasma Fractionation Technology Product Portfolio
- 12.13.5 Shuanglin Bio Recent Developments
- 12.14 Boya Bio
- 12.14.1 Boya Bio Company Information
- 12.14.2 Boya Bio Business Overview
- 12.14.3 Boya Bio Revenue in Plasma Fractionation Technology Business (2021-2026)
- 12.14.4 Boya Bio Plasma Fractionation Technology Product Portfolio
- 12.14.5 Boya Bio Recent Developments
- 12.15 Yuanda Shuyang
- 12.15.1 Yuanda Shuyang Company Information
- 12.15.2 Yuanda Shuyang Business Overview
- 12.15.3 Yuanda Shuyang Revenue in Plasma Fractionation Technology Business (2021-2026)
- 12.15.4 Yuanda Shuyang Plasma Fractionation Technology Product Portfolio
- 12.15.5 Yuanda Shuyang Recent Developments
- 12.16 Weiguang Bio
- 12.16.1 Weiguang Bio Company Information
- 12.16.2 Weiguang Bio Business Overview
- 12.16.3 Weiguang Bio Revenue in Plasma Fractionation Technology Business (2021-2026)
- 12.16.4 Weiguang Bio Plasma Fractionation Technology Product Portfolio
- 12.16.5 Weiguang Bio Recent Developments
- 12.17 Nanyue Bio
- 12.17.1 Nanyue Bio Company Information
- 12.17.2 Nanyue Bio Business Overview
- 12.17.3 Nanyue Bio Revenue in Plasma Fractionation Technology Business (2021-2026)
- 12.17.4 Nanyue Bio Plasma Fractionation Technology Product Portfolio
- 12.17.5 Nanyue Bio Recent Developments
- 12.18 KM Biologics
- 12.18.1 KM Biologics Company Information
- 12.18.2 KM Biologics Business Overview
- 12.18.3 KM Biologics Revenue in Plasma Fractionation Technology Business (2021-2026)
- 12.18.4 KM Biologics Plasma Fractionation Technology Product Portfolio
- 12.18.5 KM Biologics Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst